```
REGISTERED CHARITY NUMBER: 1182494
```
```
Report of the Trustees and
```
```
Unaudited Financial Statements
for the Year Ended 5 April 2024
```
```
for
```
```
BRITISH COCHLEAR IMPLANT GROUP CIO
```
```
Sandison Lang Limited
2 St Marys Road
Tonbridge
Kent
TN9 2LB
```
## **`BRITISH COCHLEAR IMPLANT GROUP CIO`**
```
Contents of the Financial Statements
for the Year Ended 5 April 2024
```
||**`Page`**|
|---|---|
|**`Report of the Trustees`**|`1 to 2`|
|**`Independent Examiner's Report`**|`3`|
|**`Statement of Financial Activities`**|`4`|
|**`Balance Sheet`**|`5`|
|**`Notes to the Financial Statements`**|`6 to 10`|
|**`Detailed Statement of Financial Activities`**|`11 to 12`|
```
BRITISH COCHLEAR IMPLANT GROUP CIO
```
## **`Report of the Trustees`**
```
for the Year Ended 5 April 2024
```
```
The trusteespresenttheirreportwith the financialstatementsof the charityfor the yearended 5 April 2024.
ThetrusteeshaveadoptedtheprovisionsofAccountingandReportingbyCharities:Statement of
RecommendedPracticeapplicabletocharitiespreparingtheiraccountsinaccordancewiththe Financial
Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 January 2019).
```
## **`OBJECTIVES AND ACTIVITIES`**
## **`Objectives and aims`**
```
For the public benefit to advanceknowledge,best practiceand awarenessin the field of hearing implantation,
in particularthroughthedisseminationofcochlearimplantresearchtohealthprofessionalsand information
tothepublicin ordertoimprovehearing,communicationandqualityoflifeofhearing-impairedpeople and
their families.
```
## **`Significant activities`**
```
We as Charityto provideinformationto all professionalsand implantrecipients.We haveannual conference
andsomewebinarsessions.Weattendotherconferencestoincreasedtheawarenessofcochlear implants.
Wehaveatleastoncefacetofacemeetinginoneyearandseveralonlinemeetings.Weaccept job
advertisement.
```
## **`STRUCTURE, GOVERNANCE AND MANAGEMENT`**
## **`Governing document`**
```
Thecharityiscontrolledbyitsgoverningdocument,adeedoftrustandconstitutesan unincorporated
charity.
```
## **`REFERENCE AND ADMINISTRATIVE DETAILS`**
## **`Registered Charity number`**
```
1182494
```
## **`Principal address`**
```
Yorkshire Auditory Implant Service
Bradford Royal Infirmary
Duckworth Lane
Bradford
BD9 6RJ
```
## **`Trustees`**
```
Professor M Bance
E Stapleton
J Gallacher
J Townsend
Dr Y Guo (appointed 14.4.2023)
R McTaggart (appointed 14.4.2023)
C Killan (appointed 14.4.2023)
H Meakin
A Banerjee
C Totten (appointed 14.4.2023)
```
```
Page 1
```
## **`BRITISH COCHLEAR IMPLANT GROUP CIO`**
## **`Report of the Trustees`**
```
for the Year Ended 5 April 2024
```
## **`REFERENCE AND ADMINISTRATIVE DETAILS`**
## **`Independent Examiner`**
```
Sandison Lang Limited
2 St Marys Road
Tonbridge
Kent
TN9 2LB
```
```
Approved by order of the board of trustees on 11 February 2025 and signed on its behalf by:
```
```
Dr Y Guo - Trustee
```
```
Page 2
```
```
Independent Examiner's Report to the Trustees of
British Cochlear Implant Group CIO
```
## **`Independent examiner's report to the trustees of British Cochlear Implant Group CIO`**
```
I reportto the charitytrusteeson my examinationof the accountsof BritishCochlearImplantGroupCIO (the
Trust) for the year ended 5 April 2024.
```
## **`Responsibilities and basis of report`**
```
As the charitytrusteesof the Trust you are responsiblefor the preparationof the accountsin accordance with
the requirements of the Charities Act 2011 ('the Act').
```
```
I reportin respectofmyexaminationoftheTrust'saccountscarriedoutunderSection145oftheActand in
carryingoutmyexaminationI havefollowedall applicableDirectionsgivenby the CharityCommission under
Section 145(5)(b) of the Act.
```
## **`Independent examiner's statement`**
```
Ihavecompletedmyexamination.Iconfirmthatnomaterialmattershavecometomyattention in
connection with the examination giving me cause to believe that in any material respect:
```
`1. accounting records were not kept in respect of the Trust as required by Section 130 of the Act; or`
`2. the accounts do not accord with those records; or`
`3. the accounts do not comply with the applicable requirements concerning the form and content of accounts set out in the Charities (Accounts and Reports) Regulations 2008 other than any requirement that the accounts give a true and fair view which is not a matter considered as part of an independent examination.`
```
Ihavenoconcernsandhavecomeacrossnoothermattersinconnectionwiththeexaminationto which
attentionshouldbedrawninthisreportinordertoenableaproperunderstandingoftheaccountsto be
reached.
```
```
Mr Ryan Cottington ACA
```
```
Sandison Lang Limited
2 St Marys Road
Tonbridge
Kent
TN9 2LB
```
```
11 February 2025
```
```
Page 3
```
## **`BRITISH COCHLEAR IMPLANT GROUP CIO`**
## **`Statement of Financial Activities`**
## **`for the Year Ended 5 April 2024`**
|||**`2024`**|`2023`|
|---|---|---|---|
|||**`Unrestricted`**||
|||**`fund`**|`Total funds`|
||`Notes`|**`£`**|`£`|
|**`INCOME AND ENDOWMENTS FROM`**||||
|`Donations and legacies`||**`27,071`**|`31,781`|
|`Other trading activities`|`2`|**`-`**|`3,000`|
|`Investment income`|`3`|**`155`**|`28`|
|**`Total`**||**`27,226`**|`34,809`|
|**`EXPENDITURE ON`**||||
|`Raising funds`|`4`|**`-`**|`25,369`|
|`Other`||**`45,594`**|`36,191`|
|**`Total`**||**`45,594`**|`61,560`|
|**`NET INCOME/(EXPENDITURE)`**||**`(18,368)`**|`(26,751)`|
|**`RECONCILIATION OF FUNDS`**||||
|`Total funds brought forward`||**`146,178`**|`172,929`|
|**`TOTAL FUNDS CARRIED FORWARD`**||**`127,810`**|`146,178`|
```
The notes form part of these financial statements
```
```
Page 4
```
## **`BRITISH COCHLEAR IMPLANT GROUP CIO`**
## **`Balance Sheet`**
## **`5 April 2024`**
|||**`2024`**|`2023`|
|---|---|---|---|
|||**`Unrestricted`**||
|||**`fund`**|`Total funds`|
||`Notes`|**`£`**|`£`|
|**`CURRENT ASSETS`**||||
|`Cash at bank`||**`128,644`**|`146,864`|
|**`CREDITORS`**||||
|`Amounts falling due within one year`|`7`|**`(834)`**|`(686)`|
|**`NET CURRENT ASSETS`**||**`127,810`**|`146,178`|
|**`TOTAL ASSETS LESS CURRENT LIABILITIES`**||**`127,810`**|`146,178`|
|**`NET ASSETS`**||**`127,810`**|`146,178`|
|**`FUNDS`**|`8`|||
|`Unrestricted funds`||**`127,810`**|`146,178`|
|**`TOTAL FUNDS`**||**`127,810`**|`146,178`|
```
ThefinancialstatementswereapprovedbytheBoardofTrusteesandauthorisedforissue on
11 February 2025 and were signed on its behalf by:
```
```
Y Guo - Trustee
```
```
The notes form part of these financial statements
```
```
Page 5
```
```
BRITISH COCHLEAR IMPLANT GROUP CIO
```
```
for the Year Ended 5 April 2024
```
## **`Notes to the Financial Statements`**
## **`1. ACCOUNTING POLICIES`**
## **`Basis of preparing the financial statements`**
```
Thefinancialstatementsofthecharity,whichisapublicbenefitentityunderFRS102,have been
preparedinaccordancewiththeCharitiesSORP(FRS102)'AccountingandReportingby Charities:
StatementofRecommendedPracticeapplicabletocharitiespreparingtheiraccountsin accordance
withthe FinancialReportingStandardapplicablein the UK and Republicof Ireland(FRS102) (effective
1 January2019)',FinancialReportingStandard102'TheFinancialReportingStandardapplicablein the
UKandRepublicofIreland'andtheCharitiesAct2011.Thefinancialstatementshavebeen prepared
under the historical cost convention.
```
## **`Income`**
```
All incomeis recognisedin the Statementof FinancialActivitiesonce the charityhas entitlementto the
funds, it is probable that the income will be received and the amount can be measured reliably.
```
## **`Expenditure`**
```
Liabilitiesarerecognisedasexpenditureassoonasthereisalegalorconstructive obligation
committingthecharitytothatexpenditure,itisprobablethatatransferofeconomicbenefitswill be
requiredinsettlementandtheamountoftheobligationcanbemeasuredreliably.Expenditure is
accountedforonanaccrualsbasisandhasbeenclassifiedunderheadingsthataggregateall cost
relatedtothecategory.Wherecostscannotbedirectlyattributedtoparticularheadingsthey have
been allocated to activities on a basis consistent with the use of resources.
```
## **`Taxation`**
```
The charity is exempt from tax on its charitable activities.
```
## **`Fund accounting`**
```
Unrestrictedfundscanbeusedinaccordancewiththecharitableobjectivesatthediscretionof the
trustees.
```
```
Restrictedfundscanonlybeusedforparticularrestrictedpurposeswithintheobjectsofthe charity.
Restrictionsarisewhenspecifiedbythedonororwhenfundsareraisedforparticular restricted
purposes.
```
```
Furtherexplanationofthenatureandpurposeofeachfundisincludedinthenotestothe financial
statements.
```
```
continued...
```
```
Page 6
```
## **`BRITISH COCHLEAR IMPLANT GROUP CIO`**
## **`Notes to the Financial Statements - continued`**
```
for the Year Ended 5 April 2024
```
## **`2. OTHER TRADING ACTIVITIES`**
|`Sponsorships`
**`3.`**
**`INVESTMENT INCOME`**
`Deposit account interest`
**`4.`**
**`RAISING FUNDS`**
**`Raising donations and legacies`**
`Support costs`
**`5.`**
**`TRUSTEES' REMUNERATION AND BENEFITS`**||**`2024`**
**`£`**
**`-`**
**`2024`**
**`£`**
**`155`**
**`2024`**
**`£`**
**`-`**|`2023`
`£`
`3,000`
`2023`
`£`
`28`
`2023`
`£`
`25,369`|`2023`
`£`
`3,000`|
|---|---|---|---|---|
|||||`2023`
`£`
`28`|
||||||
```
Therewerenotrustees'remunerationorotherbenefitsfortheyearended5April2024norfor the
year ended 5 April 2023.
```
## **`Trustees' expenses`**
```
Therewerenotrustees'expensespaidfortheyearended5April2024norfortheyear ended
5 April 2023.
```
## **`6. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES`**
||`Unrestricted`|
|---|---|
||`fund`|
||`£`|
|**`INCOME AND ENDOWMENTS FROM`**||
|`Donations and legacies`|`31,781`|
|`Other trading activities`|`3,000`|
|`Investment income`|`28`|
|**`Total`**|`34,809`|
|**`EXPENDITURE ON`**||
|`Raising funds`|`25,369`|
```
continued...
```
```
Page 7
```
```
BRITISH COCHLEAR IMPLANT GROUP CIO
```
## **`Notes to the Financial Statements - continued`**
```
for the Year Ended 5 April 2024
```
## **`6. COMPARATIVES FOR THE STATEMENT OF FINANCIAL ACTIVITIES - continued`**
|||||`Unrestricted`|
|---|---|---|---|---|
|||||`fund`|
|||||`£`|
||`Other`|||`36,191`|
||**`Total`**|||`61,560`|
||**`NET INCOME/(EXPENDITURE)`**|||`(26,751)`|
||**`RECONCILIATION OF FUNDS`**||||
||`Total funds brought forward`|||`172,929`|
||**`TOTAL FUNDS CARRIED FORWARD`**|||`146,178`|
|**`7.`**|**`CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR`**||||
||||**`2024`**|`2023`|
||||**`£`**|`£`|
||`Trade creditors`||**`834`**|`686`|
|**`8.`**|**`MOVEMENT IN FUNDS`**||||
||||`Net`||
||||`movement`||
|||`At 6/4/23`|`in funds`|`At 5/4/24`|
|||`£`|`£`|`£`|
||**`Unrestricted funds`**||||
||`General fund`|**`146,178`**|**`(18,368)`**|**`127,810`**|
||**`TOTAL FUNDS`**|**`146,178`**|**`(18,368)`**|**`127,810`**|
```
continued...
```
```
Page 8
```
```
BRITISH COCHLEAR IMPLANT GROUP CIO
```
```
for the Year Ended 5 April 2024
```
## **`Notes to the Financial Statements - continued`**
## **`8. MOVEMENT IN FUNDS - continued`**
```
Net movement in funds, included in the above are as follows:
```
||`Incoming`|`Resources`|`Movement`|
|---|---|---|---|
||`resources`|`expended`|`in funds`|
||`£`|`£`|`£`|
|**`Unrestricted funds`**||||
|`General fund`|**`27,226`**|**`(45,594)`**|**`(18,368)`**|
|**`TOTAL FUNDS`**|**`27,226`**|**`(45,594)`**|**`(18,368)`**|
## **`Comparatives for movement in funds`**
|||`Net`||
|---|---|---|---|
|||`movement`||
||`At 6/4/22`|`in funds`|`At 5/4/23`|
||`£`|`£`|`£`|
|**`Unrestricted funds`**||||
|`General fund`|`172,929`|`(26,751)`|`146,178`|
|**`TOTAL FUNDS`**|`172,929`|`(26,751)`|`146,178`|
```
Comparative net movement in funds, included in the above are as follows:
```
||`Incoming`|`Resources`|`Movement`|
|---|---|---|---|
||`resources`|`expended`|`in funds`|
||`£`|`£`|`£`|
|**`Unrestricted funds`**||||
|`General fund`|`34,809`|`(61,560)`|`(26,751)`|
|**`TOTAL FUNDS`**|`34,809`|`(61,560)`|`(26,751)`|
```
continued...
```
```
Page 9
```
```
BRITISH COCHLEAR IMPLANT GROUP CIO
```
## **`Notes to the Financial Statements - continued`**
```
for the Year Ended 5 April 2024
```
## **`8. MOVEMENT IN FUNDS - continued`**
```
A current year 12 months and prior year 12 months combined position is as follows:
```
|||`Net`||
|---|---|---|---|
|||`movement`||
||`At 6/4/22`|`in funds`|`At 5/4/24`|
||`£`|`£`|`£`|
|**`Unrestricted funds`**||||
|`General fund`|`172,929`|`(45,119)`|`127,810`|
|**`TOTAL FUNDS`**|`172,929`|`(45,119)`|`127,810`|
```
A currentyear12 monthsand prioryear12 monthscombinednet movementin funds,includedin the
above are as follows:
```
||`Incoming`|`Resources`|`Movement`|
|---|---|---|---|
||`resources`|`expended`|`in funds`|
||`£`|`£`|`£`|
|**`Unrestricted funds`**||||
|`General fund`|`62,035`|`(107,154)`|`(45,119)`|
|**`TOTAL FUNDS`**|`62,035`|`(107,154)`|`(45,119)`|
## **`9. RELATED PARTY DISCLOSURES`**
```
There were no related party transactions for the year ended 5 April 2024.
```
```
Page 10
```
## **`BRITISH COCHLEAR IMPLANT GROUP CIO`**
## **`Detailed Statement of Financial Activities`**
```
for the Year Ended 5 April 2024
```
|**`INCOME AND ENDOWMENTS`**
**`Donations and legacies`**
`Subscriptions`
`Advertising Income`
**`Other trading activities`**
`Sponsorships`
**`Investment income`**
`Deposit account interest`
**`Total incoming resources`**
**`EXPENDITURE`**
**`Other`**
`Subscription costs`
`Travel & Meeting Expenses`
**`Support costs`**
**`Management`**
`Administration support`
`Insurance`
`Advertising and design`
`Sundries`
`Website & IT Support Fees`
**`Finance`**
`Bank charges`
**`Governance costs`**
`Accountancy and legal fees`|`2024`
`£`
**`25,821`**
**`1,250`**
**`27,071`**
**`-`**
**`155`**
**`27,226`**
**`9,000`**
**`2,027`**
**`11,027`**
**`19,239`**
**`154`**
**`2,744`**
**`1,773`**
**`9,823`**
**`33,733`**
**`-`**
**`834`**|`2023`
`£`
`30,881`
`900`|
|---|---|---|
|||`31,781`
`3,000`
`28`|
|||`34,809`
`20,981`
`816`|
|||`21,797`
`13,131`
`171`
`894`
`589`
`23,700`|
|||`38,485`
`15`
`1,263`|
```
This page does not form part of the statutory financial statements
```
```
Page 11
```
## **`BRITISH COCHLEAR IMPLANT GROUP CIO`**
## **`Detailed Statement of Financial Activities`**
```
for the Year Ended 5 April 2024
```
|`Total resources expended`
**`Net expenditure`**|`2024`
`£`
**`45,594`**
**`(18,368)`**|`2023`
`£`
`61,560`
`(26,751)`|
|---|---|---|
```
This page does not form part of the statutory financial statements
```
```
Page 12
```